Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2018 (2018), Article ID 9739236, 9 pages
Review Article

Mending a Broken Heart: Treatment of Stress-Induced Heart Failure after Solid Organ Transplantation

1Division of Abdominal Transplantation and Hepatobiliary Surgery, Baylor College of Medicine, 6620 Main Street, Suite 1425, Houston, TX 77030, USA
2University of Texas Health Science Center at San Antonio, UT Transplant Center, 4502 Medical Drive, San Antonio, TX 78229, USA

Correspondence should be addressed to N. Thao Galván; ude.mcb@navlag.oaht

Received 21 August 2017; Revised 3 December 2017; Accepted 14 December 2017; Published 18 February 2018

Academic Editor: Andreas Zuckermann

Copyright © 2018 N. Thao Galván et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Stress-induced heart failure, also known as Broken Heart Syndrome or Takotsubo Syndrome, is a phenomenon characterized as rare but well described in the literature, with increasing incidence. While more commonly associated with postmenopausal women with psychiatric disorders, this entity is found in the postoperative patient. The nonischemic cardiogenic shock manifests as biventricular failure with significant decreases in ejection fraction and cardiac function. In a review of over 3000 kidney and liver transplantations over the course of 17 years within two transplant centers, we describe a series of 7 patients with Takotsubo Syndrome after solid organ transplantation. Furthermore, we describe a novel approach of successfully treating the transient, though potentially fatal, cardiogenic shock with a percutaneous ventricular assistance device in two liver transplant patients, while treating one kidney transplant patient medically and the remaining four liver transplant patients with an intra-aortic balloon pump. We describe our experience with Takotsubo’s Syndrome and compare the three modalities of treatment and cardiac augmentation. Our series is novel in introducing the percutaneous ventricular assist device as a more minimally invasive intervention in treating nonischemic heart failure in the solid organ transplant patient, while serving as a comprehensive overview of treatment modalities for stress-induced heart failure.